Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > UTHR United Therapeutics > Detailed Quotes

UTHR United Therapeutics

Watchlist
259.680
-4.550-1.72%
Close  01/27 16:00 ET
259.6800.0000.00%
Post Mkt Price 01/27 16:17 ET
High
263.970
Open
263.500
Turnover
56.68M
Low
258.170
Pre Close
264.230
Volume
218.00K
Market Cap
11.84B
P/E(TTM)
17.68
52wk High
283.090
Shares
45.58M
P/E(Static)
25.81
52wk Low
158.380
Float Cap
10.05B
Bid/Ask %
0.00%
Historical High
283.090
Shs Float
38.70M
Volume Ratio
0.76
Historical Low
4.275
Dividend TTM
--
Div Yield TTM
--
P/B
2.59
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.56%
Amplitude
2.20%
Avg Price
260.020
Lot Size
1
Float Cap
10.05B
Bid/Ask %
0.00%
Historical High
283.090
Shs Float
38.70M
Volume Ratio
0.76
Historical Low
4.275
Dividend TTM
--
P/B
2.59
Dividend LFY
--
Turnover Ratio
0.56%
Amplitude
2.20%
Avg Price
260.020
Lot Size
1
Price Forecast

News

Comment

Company Overview More
United Therapeutics Corp. operates as a biotechnology company engaged in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It is involved in the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. The company was founded by Martine A. Rothblatt on June 26, 1996, and is headquartered in Silver Spring, MD.
CEO: Dr. Martine A. Rothblatt
Market: NASDAQ
Listing Date: 06/17/1999
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist